Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Immunology
Volume 2015, Article ID 216362, 4 pages
http://dx.doi.org/10.1155/2015/216362
Case Report

Refractory Immunological Thrombocytopenia Purpura and Splenectomy in Pregnancy

1Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogotá, Colombia
2Surgery Department, School of Medicine and Health Sciences, Universidad del Rosario, Bogotá, Colombia
3Surgery Department, Hospital Universitario Mayor-Mederi (HUM), Bogotá, Colombia
4Gynaecology Department, Hospital Universitario Mayor-Mederi (HUM), Bogotá, Colombia

Received 20 August 2015; Revised 30 November 2015; Accepted 8 December 2015

Academic Editor: Christian Drouet

Copyright © 2015 Santiago Bernal-Macías et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Á. Sanz, V. Vicente García, A. Fernández et al., “Guidelines for diagnosis, treatment and monitoring of primary immune thrombocytopenia,” Medicina Clinica, vol. 138, no. 6, pp. 261.e1–261.e17, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Strong, “Bleeding disorders in pregnancy,” Current Obstetrics & Gynaecology, vol. 13, pp. 1–6, 2003. View at Google Scholar
  3. D. B. Cines and V. S. Blanchette, “Medical progress: immune thrombocytopenic purpura,” The New England Journal of Medicine, vol. 346, no. 13, pp. 995–1008, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. British Committee for Standards in Haematology General Haematology Task Force, “Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy,” British Journal of Haematology, vol. 120, no. 4, pp. 574–596, 2003. View at Publisher · View at Google Scholar
  5. C. Neunert, W. Lim, M. Crowther, A. Cohen, L. Solberg Jr., and M. A. Crowther, “The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia,” Blood, vol. 117, no. 16, pp. 4190–4207, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Diz-Küçükkaya, A. Hacihanefioğlu, M. Yenerel et al., “Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with immune thrombocytopenic purpura: a prospective cohort study,” Blood, vol. 98, no. 6, pp. 1760–1764, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. Y.-J. Yang, G.-W. Yun, I.-C. Song et al., “Clinical implications of elevated antiphospholipid antibodies in adult patients with primary immune thrombocytopenia,” The Korean Journal of Internal Medicine, vol. 26, no. 4, pp. 449–454, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Stasi, E. Stipa, M. Masi et al., “Prevalence and clinical significance of elevated antiphospholipid antibodies in patients with idiopathic thrombocytopenic purpura,” Blood, vol. 84, no. 12, pp. 4203–4208, 1994. View at Google Scholar · View at Scopus
  9. R. Cervera, M. G. Tektonidou, G. Espinosa et al., “Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (II): thrombocytopenia and skin manifestations,” Lupus, vol. 20, no. 2, pp. 174–181, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Marchetti, M. Cohen, and P. De Moerloose, “Obstetrical antiphospholipid syndrome: from the pathogenesis to the clinical and therapeutic implications,” Clinical and Developmental Immunology, vol. 2013, Article ID 159124, 9 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Miyakis, M. D. Lockshin, T. Atsumi et al., “International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS),” Journal of Thrombosis and Haemostasis, vol. 4, no. 2, pp. 295–306, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Rojas-Villarraga, J. Amaya-Amaya, A. Rodriguez-Rodriguez, R. D. Mantilla, and J.-M. Anaya, “Introducing polyautoimmunity: secondary autoimmune diseases no longer exist,” Autoimmune Diseases, vol. 2012, Article ID 254319, 9 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. B. V. Anglin, C. Rutherford, R. Ramus, M. Lieser, and D. B. Jones, “Immune thrombocytopenic purpura during pregnancy: laparoscopic treatment,” Journal of the Society of Laparoendoscopic Surgeons, vol. 5, no. 1, pp. 63–67, 2001. View at Google Scholar · View at Scopus
  14. W. F. Rayburn, “Glucocorticoid therapy for rheumatic diseases: maternal, fetal, and breast-feeding considerations,” American Journal of Reproductive Immunology, vol. 28, no. 3-4, pp. 138–140, 1992. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Cuker and D. B. Cines, “Immune thrombocytopenia,” Hematology, vol. 2010, no. 1, pp. 377–384, 2010. View at Publisher · View at Google Scholar
  16. J. R. Stratton, P. J. Ballem, T. Gernsheimer, M. Cerqueira, and S. J. Slichter, “Platelet destruction in autoimmune thrombocytopenic purpura: kinetics and clearance of indium-111-labeled autologous platelets,” Journal of Nuclear Medicine, vol. 30, no. 5, pp. 629–637, 1989. View at Google Scholar · View at Scopus
  17. T. Gernsheimer, A. H. James, and R. Stasi, “How I treat thrombocytopenia in pregnancy,” Blood, vol. 121, no. 1, pp. 38–47, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Mahey, S. D. Kaur, S. Chumber, A. Kriplani, and N. Bhatla, “Splenectomy during pregnancy: treatment of refractory immune thrombocytopenic purpura,” BMJ Case Reports, vol. 2013, 2013. View at Google Scholar · View at Scopus
  19. T. W. Felbinger, M. Posner, H. K. Eltzschig, and B. S. Kodali, “Laparoscopic splenectomy in a pregnant patient with immune thrombocytopenic purpura,” International Journal of Obstetric Anesthesia, vol. 16, no. 3, pp. 281–283, 2007. View at Publisher · View at Google Scholar · View at Scopus